Work

Abstract LB404: A new biomarker measuring signal of immune activation (SIA) can improve prediction of response to immune checkpoint inhibitor (ICI) regimens in malignant melanoma

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-lb404

Authors: Emma Sandberg, Artur Mezheyeuski, Chatarina Larsson, Tobias Sjöblom

Institutions: Uppsala University, Vall d'Hebron Institute of Oncology

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409820800

Cites:

Cited by:

Related to: 10